Cell Signaling Technology

Itk (2F12) Mouse Monoclonal Antibody

#2380 · $180

100
Citing papers
23.7k
Combined citations
Supplier page Find this product

Research areas

Sirtuins and Resveratrol in Medicine19Autophagy in Disease and Therapy11Lung Cancer Treatments and Mutations10MicroRNA in disease regulation9NF-κB Signaling Pathways8Immune Response and Inflammation8Cancer-related molecular mechanisms research6Genomics, phytochemicals, and oxidative stress5

Papers citing this product

1
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
Journal of Clinical Investigation·2000·1.4k cit.·DOI
2
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Nature Microbiology·2020·1.4k cit.·DOI
3
EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition
Institutional Repositories DataBase (IRDB)·2014·741 cit.
4
Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus
Journal of Biological Chemistry·2004·672 cit.·DOI
5
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
Nature Communications·2016·657 cit.·DOI
6
Chronic Sleep Disruption Alters Gut Microbiota, Induces Systemic and Adipose Tissue Inflammation and Insulin Resistance in Mice
Scientific Reports·2016·466 cit.·DOI
7
Motif module map reveals enforcement of aging by continual NF-κB activity
Genes & Development·2007·454 cit.·DOI
8
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor <i>BRAF</i> gene mutations but lack mutations in <i>KRAS, NRAS,</i> or <i>MEK1</i>
Proceedings of the National Academy of Sciences·2012·436 cit.·DOI
9
Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer
Nature Communications·2017·409 cit.·DOI
10
TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer
Proceedings of the National Academy of Sciences·2010·385 cit.·DOI

Similar products

ProductVendorPricePapers
Itk (2F12) Mouse Monoclonal Antibody (Biotinylated)MouseCell Signaling Technology$556200
ITK (E4X7M) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology$86546
ITK (E4X7M) Rabbit Monoclonal Antibody (Biotinylated)RabbitCell Signaling Technology$5565
ITK (E4X7M) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$1762
Itk (2F12) Mouse Monoclonal Antibody — Evidence — PubIndex